UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000043672
Receipt No. R000049871
Scientific Title A study on the viability of bifidobacteria ingested as an acid-resistant processed preparation in the digestive tract. -Single group before-after test-
Date of disclosure of the study information 2021/09/01
Last modified on 2021/09/17 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study on the arrival of live bifidobacteria in the gastrointestinal tract. -Single group before-after test-
Acronym Study on the arrival of live bifidobacteria in the gastrointestinal tract.
Scientific Title A study on the viability of bifidobacteria ingested as an acid-resistant processed preparation in the digestive tract. -Single group before-after test-
Scientific Title:Acronym A study on the viability of bifidobacteria ingested as an acid-resistant processed preparation in the digestive tract.
Region
Japan

Condition
Condition Healthy volunteer
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Verification of survival of bifidobacteria in human feces before and after ingestion of acid-resistant bifidobacteria supplement
Basic objectives2 Others
Basic objectives -Others Verification of supplement on acid resistance processing technology
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Detection of certain live Bifidobacterium in feces.
Time: Before and after the intervention (0day, 14days)
Key secondary outcomes Viable cell count of certain Bifidobacterium in feces

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Bifidobacterium-containing acid-resistant preparation
Intervention period:14days
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria 1.Healthy men and women 20 to 64 years old
2.Subjects who have defecation every day and can collect stool at the designated date and time
3.Subjects who have received sufficient explanation about the purpose and content of the exam, have the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the exam in writing.
Key exclusion criteria 1. Subjects who tend to have loose stools or constipation
2. Subjects who cannot stop the intake of foods containing certain Bifidobacterium from the screening test to the end of the 2-week test.
3. Subjects who are taking drugs that affect digestion and absorption, such as antibiotics
4. Subjects who cannot stop the intake of medicines, quasi-drugs, and health foods that affect the test during the test period.
5. Subjects with food allergies
6. Subjects who consume a large amount of alcohol on a daily basis
7. Subjects who have urgent medical treatment or have serious complications
8. Subjects with digestive disorders or surgical history that affect digestion and absorption and defecation
9. Subjects with a history of irritable bowel syndrome or a current medical history
10. Subjects background Persons who are judged to be inappropriate as subjects based on the answers to the questionnaire
11. Pregnant, willing to become pregnant during the exam, breastfeeding
12. Subjects with a history of drug dependence, alcohol dependence, or current medical history
13. Subjects who have participated in or are willing to participate in tests that take other foods or use drugs, and tests that apply cosmetics and drugs
14. Subjects judged as unsuitable for the study by the investigator for other reasons
Target sample size 10

Research contact person
Name of lead principal investigator
1st name Kei
Middle name
Last name Yui
Organization FANCL Corporation
Division name Research Institute, Health science research center
Zip code 244-0806
Address 12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa
TEL 045-820-3443
Email ke-yui@fancl.co.jp

Public contact
Name of contact person
1st name Eiji
Middle name
Last name Yoshikawa
Organization KSO Corporation
Division name Sales department
Zip code 105-0023
Address 1-9-7, Shibaura, Minato-ku, Tokyo The 7th floor of Shibaura omodaka building
TEL 03-3452-7733
Homepage URL
Email yoshikawa@kso.co.jp

Sponsor
Institute KSO Corporation
Institute
Department

Funding Source
Organization FANCL Corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethical Committee of Kobuna Orthopedics Clinic
Address 5-656-17Joutou-machi,Maebashi-shi,Gunma
Tel 027-212-5608
Email sagawa@mc-connect.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 品川シーズンテラス健診クリニック/Shinagawa Season Terrace Health Care Clinic

Other administrative information
Date of disclosure of the study information
2021 Year 09 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2021 Year 03 Month 02 Day
Date of IRB
2021 Year 03 Month 04 Day
Anticipated trial start date
2021 Year 03 Month 21 Day
Last follow-up date
2021 Year 04 Month 25 Day
Date of closure to data entry
2021 Year 05 Month 10 Day
Date trial data considered complete
2021 Year 05 Month 20 Day
Date analysis concluded
2021 Year 06 Month 30 Day

Other
Other related information

Management information
Registered date
2021 Year 03 Month 19 Day
Last modified on
2021 Year 09 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049871